In vivo antileishmanial activity of Annona mucosa extracts

Rev Soc Bras Med Trop. 2020 Jan 27:53:e20190139. doi: 10.1590/0037-8682-0139-2019. eCollection 2020.

Abstract

Introduction: Leishmaniasis, a disease caused by a parasite endemic to large areas of tropical and subtropical countries, is a growing public health problem.

Methods: Male BALB/c mice were infected with Leishmania amazonensis and treated with extracts isolated from Annona mucosa.

Results: Treated groups had significantly reduced footpad swelling. The group treated intraperitoneally with hexane extract showed footpad swelling similar to groups treated with Pentamidine® and Glucantime®. Groups treated with dichloromethane extract and hexane extract presented the recovering phenotype associated with reduced parasite levels.

Conclusions: Extracts of A. mucosa are promising sources of novel antileishmanial compounds.

MeSH terms

  • Animals
  • Annona / chemistry*
  • Antiprotozoal Agents / isolation & purification
  • Antiprotozoal Agents / therapeutic use*
  • Disease Models, Animal
  • Leishmania / drug effects*
  • Leishmaniasis, Cutaneous / drug therapy*
  • Leishmaniasis, Cutaneous / parasitology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Plant Extracts / therapeutic use*

Substances

  • Antiprotozoal Agents
  • Plant Extracts